Plasma levels of plasminogen activator inhibitor type 1, factor VIII, prothrombin activation fragment 1+2, anticardiolipin, and antiprothrombin antibodies are risk factors for thrombosis in hemodialysis patients
Authors:
- Natale G. De SantoNSNatale G. De Santo
- Rosa MarottaRMRosa Marotta
- Pietro AnastasioPAPietro Anastasio
- Mahrokh MosavatMMMahrokh Mosavat
- Domenico De LuciaDLDomenico De Lucia
- 1 September 2004
- journal article
- Published by Elsevier in Seminars in Nephrology
- Vol. 24 (5) , 495-501
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Oxidative stress and inflammation in hemodialysis patientsAmerican Journal of Kidney Diseases, 2001
- Hypercoagulopathy in a Hemodialysis Patient: Are Elevations in Factors VII and VIII Effective?Nephron, 1999
- Increased reticulated platelets in dialysis patientsKidney International, 1997
- Evaluation of Blood Coagulation-Fibrinolysis System in Patients Receiving Chronic HemodialysisNephron, 1996
- Anticardiolipin antibody in patients on maintenance hemodialysis and its association with recurrent arteriovenous graft thrombosisAmerican Journal of Kidney Diseases, 1995
- BLEEDING IN RENAL FAILUREThe Lancet, 1988
- Platelet dysfunction in uremia. Multifaceted defect partially corrected by dialysisThe American Journal of Medicine, 1985
- Bleeding time in Uremia: A useful test to assess clinical bleedingAmerican Journal of Hematology, 1979
- Bleeding in renal failure: a possible cause.BMJ, 1976
- Haematoma of rectus abdominis associated with dialysis.BMJ, 1972